International Biotechnology Trust Plc/Fund (IBTL)

 592.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 735.00
  • 52 Week Low: 486.00
  • Currency: UK Pounds
  • Shares Issued: 39.23m
  • Volume: 0
  • Market Cap: £232.23m

Fundamentals - based on IFRS

  £ (Millions) £ (Millions) £ (Millions) £ (Millions) £ (Millions)
Income Statement 31-Aug-24 31-Aug-23 31-Aug-22 31-Aug-21 31-Aug-20
Continuing Operations          
Revenue 1.26 0.86 1.11 1.11 1.13
Operating Profit/(Loss) (1.16) (2.51) (2.11) (2.37) (1.79)
Profit Before Tax (3.36) (3.75) (2.78) (2.59) (2.06)
Profit After Tax (3.50) (3.87) (2.93) (2.75) (2.22)
           
Earnings per Share - Basic (9.16p) (9.53p) (7.13p) (6.80p) (5.79p)
Earnings per Share - Adjusted (9.16p) (9.53p) (7.13p) (6.80p) (5.79p)
           
Dividend per Share 28.40p 28.20p 31.40p 28.40p 24.80p
  £ (Millions) £ (Millions) £ (Millions) £ (Millions) £ (Millions)
Balance Sheet 31-Aug-24 31-Aug-23 31-Aug-22 31-Aug-21 31-Aug-20
Assets          
Non-Current Assets          
Property, Plant & Equipment n/a n/a n/a n/a n/a
Intangible Assets n/a n/a n/a n/a n/a
Other Non-Current Assets n/a n/a n/a n/a n/a
  297.51 301.90 313.43 345.34 302.22
Current Assets          
Inventories n/a n/a n/a n/a n/a
Cash at Bank & in Hand 10.43 n/a n/a 1.56 0.32
Other Current Assets n/a n/a n/a n/a n/a
  10.65 2.97 13.49 2.50 0.48
           
Other Assets n/a n/a n/a n/a n/a
Total Assets 308.15 304.87 326.92 347.83 302.71
Current Liabilities          
Borrowings 22.83 32.47 39.98 21.87 18.10
Other Current Liabilities 3.06 2.08 2.05 2.19 0.71
           
Current Liabilities 25.89 34.55 42.03 24.06 18.81
           
Net Current Assets cn/a cn/a cn/a cn/a cn/a
           
Borrowings n/a n/a n/a n/a n/a
Other Non-Current Liabilities n/a n/a n/a n/a n/a
Non-Current Liabilities n/a n/a n/a n/a n/a
           
Other Liabilities n/a n/a n/a n/a n/a
Total Liabilities 25.89 34.55 42.03 24.06 18.81
           
Net Assets 282.27 270.32 284.89 323.77 283.90
           
Shareholders Funds 282.27 270.32 284.89 323.77 283.90
           
Minority Interests/Other Equity n/a n/a n/a n/a n/a
Total Equity 282.27 270.32 284.89 323.77 283.90
Cash Flow 31-Aug-24 31-Aug-23 31-Aug-22 31-Aug-21 31-Aug-20
Net Cash Flow From Operating Activities 45.35 27.30 1.12 (14.53) (9.55)
Net Cash Flow from Investing Activities n/a n/a n/a n/a n/a
Net Cash Flow from Financing Activities (2.20) (21.39) (20.79) 11.99 (9.11)
Net Increase/Decrease In Cash 43.15 5.91 (19.66) (2.54) (18.66)
Ratios - based on IFRS 31-Aug-24 31-Aug-23 31-Aug-22 31-Aug-21 31-Aug-20
Continuing Operations          
PE Ratio - Adjusted n/a n/a n/a n/a n/a
PEG - Adjusted n/a n/a n/a n/a n/a
Earnings per Share Growth - Adjusted n/a n/a n/a n/a n/a
Dividend Cover (0.32) (0.34) (0.23) (0.24) (0.23)
Revenue per Share 3.22p 2.20p 2.84p 2.82p 2.89p
Pre-Tax Profit per Share (8.57p) (9.55p) (7.08p) (6.60p) (5.24p)
Operating Margin (92.08%) (290.38%) (189.94%) (214.66%) (158.29%)
Return on Capital Employed n/a n/a n/a n/a n/a
           
Dividend Yield 4.1% 4.4% 4.6% 3.9% 3.4%
Dividend per Share Growth 0.71% (10.19%) 10.56% 14.52% (11.43%)
Operating Cash Flow per Share 115.61p 69.59p 2.87p (37.05p) (24.35p)
Cash Incr/Decr per Share 110.01p 15.08p (50.13p) (6.47p) (47.56p)
Net Asset Value per Share (exc. Intangibles) 719.56p 689.10p 726.25p 825.37p 723.72p
Net Gearing 4.39% 12.01% 14.03% 6.27% 6.26%

Key

* GAAP

a. Includes discontinued activities

b. Including assets due in more than one year

c. Not disclosed under IFRS

d. Total fixed assets

e. Includes borrowings

f. Included in cash flow from operating activities under IFRS

g. Included in net cash from investing activities under IFRS

h. Pre-tax

i. Capital expenditure

j. Based on operating cash flow before tax

k. Issue of ordinary shares

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 5 minutes.

Note 2: Forecast figures based on normalised accounts.

 

Top of Page